Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-11 Purchase |
2022-08-11 4:19 pm |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
44,400 | $2.03 | $90,132 | 56,400 (Direct) |
View |
| 2022-04-25 Sale |
2022-04-27 4:34 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
8,694 | $6.0399 | $52,511 | 318,147 (Direct) |
View |
| 2022-04-20 Sale |
2022-04-22 8:04 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
1,289 | $6.0128 | $7,751 | 326,841 (Direct) |
View |
| 2022-04-11 Sale |
2022-04-13 6:10 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
32,849 | $6.8694 | $225,654 | 328,130 (Direct) |
View |
| 2022-04-06 Sale |
2022-04-08 4:21 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
2,181 | $7.5458 | $16,457 | 360,979 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 5:01 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
3,800 | $7.7168 | $29,324 | 363,160 (Direct) |
View |
| 2022-03-30 Sale |
2022-04-01 5:36 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
300 | $7.52 | $2,256 | 366,960 (Direct) |
View |
| 2022-03-25 Sale |
2022-03-29 4:29 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
10,300 | $7.5431 | $77,694 | 367,260 (Direct) |
View |
| 2022-03-21 Sale |
2022-03-24 5:32 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
4,800 | $7.5192 | $36,092 | 377,560 (Direct) |
View |
| 2022-03-17 Sale |
2022-03-21 5:47 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
3,604 | $7.5268 | $27,126 | 382,360 (Direct) |
View |
| 2022-03-14 Sale |
2022-03-16 4:29 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
1,500 | $6.9727 | $10,459 | 385,964 (Direct) |
View |
| 2022-03-09 Sale |
2022-03-14 4:18 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
2,822 | $7.0275 | $19,832 | 387,464 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 4:59 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
14,504 | $7.1666 | $103,945 | 390,286 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:53 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
27,593 | $7.4367 | $205,201 | 404,790 (Direct) |
View |
| 2022-02-24 Sale |
2022-02-28 7:13 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
13,752 | $7.5026 | $103,176 | 432,383 (Direct) |
View |
| 2022-02-18 Sale |
2022-02-23 5:58 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
38,297 | $7.7926 | $298,434 | 446,135 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-17 5:39 pm |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
47,502 | $8.0798 | $383,808 | 484,432 (Direct) |
View |
| 2021-08-23 Purchase |
2021-08-23 6:28 pm |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
2,829 | $7.985 | $22,590 | 12,000 (Direct) |
View |
| 2021-08-18 Purchase |
2021-08-20 4:10 pm |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
3,171 | $8.05 | $25,527 | 9,171 (Direct) |
View |
| 2021-08-16 Purchase |
2021-08-17 4:05 pm |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
6,000 | $8.1 | $48,600 | 6,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-14 Option Award |
2022-06-22 7:16 pm |
N/A 2032-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | Preston Heather Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-22 7:14 pm |
N/A 2032-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | Lee Philina Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-22 7:12 pm |
N/A 2032-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | Khuong Chau Quang Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-22 7:09 pm |
N/A 2032-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | GANNON STEVEN Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-22 7:07 pm |
N/A 2032-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | Duncan Barbara Gayle Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-22 7:05 pm |
N/A 2032-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | CAGNONI PABLO J Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-22 7:03 pm |
N/A 2032-06-13 |
Fusion Pharmaceuticals Inc. | FUSN | Bergstrom Donald A Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:40 pm |
N/A 2032-02-01 |
Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer |
406,600 | $0 | 406,600 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:39 pm |
N/A 2032-02-01 |
Fusion Pharmaceuticals Inc. | FUSN | Rawat Mohit President and CBO |
77,900 | $0 | 77,900 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:38 pm |
N/A 2032-02-01 |
Fusion Pharmaceuticals Inc. | FUSN | O'Leary James J Chief Medical Officer |
160,722 | $0 | 161,022 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:37 pm |
N/A 2032-02-01 |
Fusion Pharmaceuticals Inc. | FUSN | Crowley John J Chief Financial Officer |
170,910 | $0 | 177,410 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:36 pm |
N/A 2032-02-01 |
Fusion Pharmaceuticals Inc. | FUSN | Burak Eric Chief? Scientific Officer |
168,200 | $0 | 168,200 (Direct) |
View |
| 2021-11-01 Option Award |
2021-11-02 4:37 pm |
N/A 2031-11-01 |
Fusion Pharmaceuticals Inc. | FUSN | Leamon Christopher P Chief Scientific Officer |
218,000 | $0 | 218,000 (Direct) |
View |
| 2021-09-27 Option Award |
2021-09-30 4:06 pm |
N/A 2031-09-27 |
Fusion Pharmaceuticals Inc. | FUSN | Rawat Mohit President and CBO |
257,000 | $0 | 257,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:18 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | Preston Heather Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:17 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | Lee Philina Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:16 pm |
N/A 2031-06-03 |
Fusion Pharmaceuticals Inc. | FUSN | Khuong Chau Quang Director |
17,000 | $0 | 17,000 (Direct) |
View |